Quadrant Capital Group’s Precigen PGEN Stock Holding History

Quadrant Capital Group’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,459	Closed	-$2.22K	–	2772
2022 Q4	$2.22K	Buy	1,459 +1,275	+693%	+$2.19K	﹤0.01%	2383
2022 Q3	$0	Buy	+184	New	+$388	﹤0.01%	2761
2022 Q1	–	Sell	-275	Closed	-$1K	–	2644
2021 Q4	$1K	Hold	275	–	–	﹤0.01%	2370
2021 Q3	$1K	Hold	275	–	–	﹤0.01%	2365
2021 Q2	$2K	Hold	275	–	–	﹤0.01%	2137
2021 Q1	$2K	Hold	275	–	–	﹤0.01%	2104
2020 Q4	$3K	Hold	275	–	–	﹤0.01%	1860
2020 Q3	$1K	Hold	275	–	–	﹤0.01%	2030
2020 Q2	$1K	Buy	275 +175	+175%	+$595	﹤0.01%	2109
2020 Q1	$0	Hold	100	–	–	﹤0.01%	2227
2019 Q4	$0	Buy	+100	New	+$563	﹤0.01%	2473
2017 Q4	–	Sell	-145	Closed	-$2K	–	2149
2017 Q3	$2K	Hold	145	–	–	﹤0.01%	1823
2017 Q2	$0	Buy	+145	New	+$3.18K	﹤0.01%	2007

Other funds holding PGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quadrant Capital Group's PGEN Position: Q1 2023 in Review

Quadrant Capital Group sold out of Precigen (PGEN) in Q1 2023, closing a stake of 1,459 shares — an estimated $2.22K sold.

Quadrant Capital Group first reported a position in PGEN in Q2 2017 and held it in 13 quarters. The position peaked at $3K in Q4 2020. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

Quadrant Capital Group reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
Quadrant Capital Group sold 1,459 Precigen shares in Q1 2023, an estimated $2.22K.
Quadrant Capital Group first reported a position in Precigen in Q2 2017 and held it in 13 quarters.
Quadrant Capital Group's Precigen position peaked at $3K in Q4 2020.
157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on Quadrant Capital Group's 13F filing for Q1 2023, filed 11 May 2023.